Ronapreve 120mg Injection Combi Pack – Covid Medicine

Ronapreve Injection, 120 mg Two monoclonal antibodies are combined in the Combi Pack for the treatment of mild to moderate COVID-19 in adults and children 12 years of age and older who weigh more than 40 kg. If used following an early test diagnosis, it works best (within 7 to 10 days).

The Central Drug Standard Control Organization (CDSCO) granted emergency use authorization for this monoclonal antibody cocktail on May 3, 2021. Other than India, it has been given the go-ahead for usage in the US, Switzerland, Germany, Italy, France, and a number of other nations.

Ronapreve 120mg Injection Combi Pack should be given either into a vein (intravenously) or below the skin (subcutaneously) by a trained healthcare professional, preferably in a hospital setup. This is because the use of monoclonal antibodies may cause some side effects that may need immediate medical attention, such as severe allergic reactions (anaphylaxis). Patients should be monitored during and at least 1 hour after the injection.